Erasca, Inc. (ERAS) stock

ERASNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30

$15.66−0.12 (-0.76%)

Close on Nov 13, 2026Market cap $5.48BP/E –Yield 0.00%

Erasca statistics

67 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 11, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $5.48B; $272.32M
Enterprise Value: $4.53B; $146.23M
PB Ratio: 5.97; 2.00
P/TBV Ratio: 5.97; 2.22

Share statisticsIndustry

Shares Outstanding: 350M; 58M
Shares Change (YoY): 9.72%; 10.8%
Shares Change (QoQ): 12.1%; 0.50%
Float: 311M; 49M
Shares Held by Insiders: 11.0%; 11.7%
Shares Held by Institutions: 80.4%; 56.4%

Short sellingIndustry

Short Interest: 37M; –
Short Interest Change: 0.52%; -0.80%
Short % of Float: 11.9%; 9.01%
Short % of Shares Outstanding: 10.6%; 6.30%
Days to Cover: 8.89; 5.15

Stock price statisticsIndustry

52-Week High: $24.28; –
52-Week Low: $2.46; –
20-Day Moving Average: $14.82; –
50-Day Moving Average: $14.96; –
200-Day Moving Average: $15.26; –
Average True Range (14): $1.23; –
Price Change (1 Week): 8.67%; -1.15%
Price Change (1 Month): 5.31%; -4.87%
Price Change (3 Months): -14.3%; -21.0%
Price Change (6 Months): 53.1%; -20.6%
Price Change (YTD): 321.0%; -23.6%
Price Change (1 Year): 490.9%; -22.4%
Price Change (3 Years): 625.0%; -29.5%
Price Change (5 Years): -19.5%; -77.9%
Average Volume (10 Days): 6M; –
Average Volume (20 Days): 5M; –
Average Volume (90 Days): 5M; –
Relative Volume: 1.86; 0.70
Relative Strength Index (14): 53.8; 43.4
Volatility (1 Year): 102.6%; 80.1%
Beta (5 Years): 1.77; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -48.7%; -49.9%
Return on Assets (ROA): -43.4%; -40.6%
Return on Capital Employed (ROCE): -34.3%; -37.9%

Financial positionIndustry

Current Ratio: 14.89; 3.30
Quick Ratio: 21.54; 2.39

EfficiencyIndustry

Profits Per Employee: -$2.99M; -$689.41K
Employee Count: 103; 74
WACC: 14.0%; 10.2%

Income statement (TTM)Industry

Operating Income: -$327.66M; -$21.37M
Net Income: -$307.94M; -$22.35M
EBITDA: -$324.76M; -$17.21M
EPS (Diluted): -$0.99; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $947.80M; $68.68M
Net Cash (Debt): $947.80M; $17.76M
Net Cash Per Share: $2.71; $0.80
Equity (Book Value): $916.74M; $53.89M
Book Value Per Share: $2.62; $1.50
Tangible Book Value: $916.74M; $27.13M
Working Capital: $611.20M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$109.11M; -$12.38M
Capital Expenditures: -$132.00K; -$1.00M
Free Cash Flow: -$109.24M; -$18.21M
FCF Per Share: -$0.31; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -5.62%; -21.8%
FCF Yield: -1.99%; -9.44%
Dividend Yield: 0.00%; 1.88%
Shareholder Yield: 0.00%; 0.00%
Dividend Per Share: $0.00; $0.83
Years of Dividend Growth: 0; 0

Scores and fair valueIndustry

Altman Z-Score: 37.99; 0.23
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	ERAS	S&P 500	Difference	ERAS per year	S&P 500 per year
1 month	+6.0%	-3.0%	+9.0 pts
3 months	-12.3%	-2.8%	−9.5 pts
Year to date	+321.0%	+11.5%	+309.5 pts
1 year	+516.5%	+13.5%	+503.1 pts
3 years	+707.2%	+77.7%	+629.5 pts	+100.6%	+21.1%
5 years	-19.5%	+72.6%	−92.1 pts	-4.2%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

37M ERAS shares were sold short on Oct 30, 2026, up 0.5% from the previous report, or 11.93% of the shares available to trade. At recent volumes it would take 8.9 days to buy them back. Over the last 20 sessions, 54.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	37,156,627	+0.5%	4,178,064	8.9
Oct 15, 2026	36,963,404	+4.6%	5,817,191	6.3
Sep 30, 2026	35,338,107	+7.0%	5,143,537	6.9
Sep 15, 2026	33,036,139	+5.8%	4,316,648	7.7
Aug 31, 2026	31,238,099	+1.3%	3,308,858	9.4
Aug 14, 2026	30,847,289	+3.0%	3,080,346	10.0
Jul 31, 2026	29,953,849	-2.6%	4,119,030	7.3
Jul 15, 2026	30,766,629	-4.8%	5,230,546	5.9
Jun 30, 2026	32,321,195	+2.6%	7,192,412	4.5
Jun 15, 2026	31,493,422	-1.2%	5,461,564	5.8
May 29, 2026	31,891,428	+1.5%	4,255,264	7.5
May 15, 2026	31,425,335	-2.0%	4,670,591	6.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?